跳至主要内容
临床试验/NCT01378052
NCT01378052Unknown不适用

Level of DNA Methylation in People With Urothelial Carcinoma

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
urothelial carcinoma

研究概览

简要总结

Many studies previously showed the significant association between urinary arsenic profiles and urothelial carcinoma (UC) risk and observed the increased UC risk in people with lower plasma folate and higher homocysteine than those with higher plasma folate and lower homocysteine. The investigators would expect to explore the interactions among global DNA methylation, one-carbon metabolic pathway factors, urinary arsenic profiles and UC.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of urothelial carcinoma
  • The voluntary of participating the study

排除标准

  • Age smaller than 20 years
  • Pregnant women
  • Not willing to participate the study because of their personal reasons

结局指标

主要结局

urothelial carcinoma

时间窗: one year

Pathological verification of UC was done by routine urological practice including endoscopic biopsy or surgical resection of urinary tract tumors followed by histopathological examination by board-certified pathologists.

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

DNA Methylation and Urothelial Carcinoma | 临床试验